Together, these results demonstrate that RASSF2 is differentially expressed across AML subtypes and is a direct transcriptional target of the RUNX1-ETO oncofusion protein in t(8;21) AML. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.